Wal­greens CEO says it would be easy for UK phar­ma­cy op­er­a­tion Boots to run sep­a­rate­ly amid talks of split­ting: #JPM24

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

Wal­greens’ new CEO Tim Went­worth said it would be easy for Boots, the com­pa­ny’s phar­ma­cy chain in the Unit­ed King­dom, to split off and run as its own en­ti­ty.

The re­mark at End­points News’ event at the JP Mor­gan Health­care Con­fer­ence Tues­day while talk­ing through strate­gic op­tions in store for the phar­ma­cy gi­ant comes af­ter Bloomberg re­port­ed in De­cem­ber that Wal­greens is in talks to of­fload Boots. Bloomberg re­port­ed Boots could be val­ued at $8.8 bil­lion, with an IPO be­ing one of the op­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER